{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:05:17Z","timestamp":1793387117018,"version":"4.5.0"},"reference-count":211,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T00:00:00Z","timestamp":1725580800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000082","name":"Cystic Fibrosis Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000082","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["canadianjournalofdiabetes.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Diabetes"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.jcjd.2024.09.001","type":"journal-article","created":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T08:41:20Z","timestamp":1726130480000},"page":"19-28.e16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Cystic Fibrosis\u2013related Diabetes: A First Canadian Clinical Practice\u00a0Guideline"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6442-8060","authenticated-orcid":false,"given":"Ad\u00e8le","family":"Coriati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn Jane","family":"Potter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Gilmour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7366-193X","authenticated-orcid":false,"given":"Grace Y.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carly","family":"Nichols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry C.","family":"Lands","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary-Anne","family":"Doyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Boudreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4549-699X","authenticated-orcid":false,"given":"Laure","family":"Alexandre-Heymann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha L.","family":"McKinney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4423-3848","authenticated-orcid":false,"given":"Diana","family":"Sherifali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1033-8673","authenticated-orcid":false,"given":"Peter","family":"Senior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4706-5170","authenticated-orcid":false,"given":"R\u00e9mi","family":"Rabasa-Lhoret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure","family":"Alexandre-Heymann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenda N.","family":"Bendiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Bergeron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Bilodeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Chilvers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Corbeil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-H\u00e9l\u00e8ne","family":"Denis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8227-486X","authenticated-orcid":false,"given":"Gary J.","family":"Galante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Gent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori","family":"Fairservice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4111-7654","authenticated-orcid":false,"given":"Mark D.","family":"Inman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Jober","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2602-5885","authenticated-orcid":false,"given":"Tamizan","family":"Kherani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annick","family":"Lavoie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7212-1029","authenticated-orcid":false,"given":"Paola","family":"Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8368-8841","authenticated-orcid":false,"given":"Lisa","family":"Mannik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8127-3171","authenticated-orcid":false,"given":"Seth D.","family":"Marks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha L.","family":"McKinney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1560-7967","authenticated-orcid":false,"given":"John Michael","family":"Nicholson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Olivier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicky","family":"Parkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan","family":"Pohl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6381-9986","authenticated-orcid":false,"given":"Agn\u00e8s","family":"R\u00e4kel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4636-0397","authenticated-orcid":false,"given":"Megan","family":"Racey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhiza Regalado","family":"Lam Chew Tun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronalee","family":"Robert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Sherifali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7161-1752","authenticated-orcid":false,"given":"Tamara","family":"Spaic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4378-5294","authenticated-orcid":false,"given":"Amy","family":"Washington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zofia","family":"Zysman-Colman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcjd.2024.09.001_bib2","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/dmrr.2429","article-title":"Cystic fibrosis-related diabetes compared with type 1 and type 2 diabetes in adults","volume":"29","author":"Konrad","year":"2013","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.jcjd.2024.09.001_bib3","first-page":"3","article-title":"Cystic fibrosis-related diabetes: Clinical approach and knowledge gaps","volume":"46","author":"Prentice","year":"2023","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.jcjd.2024.09.001_bib4","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jcf.2022.07.014","article-title":"Insulinogenic index and early phase insulin secretion predict increased risk of worsening glucose tolerance and of cystic fibrosis-related diabetes","volume":"22","author":"Potter","year":"2023","journal-title":"J Cyst Fibros"},{"issue":"Suppl. 48","key":"10.1016\/j.jcjd.2024.09.001_bib5","first-page":"S37","article-title":"CF-related diabetes: Containing the metabolic miscreant of cystic fibrosis","volume":"52","author":"Moheet","year":"2017","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcjd.2024.09.001_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.702823","article-title":"The potential causes of cystic fibrosis-related diabetes","volume":"12","author":"Coderre","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jcjd.2024.09.001_bib7","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jcjd.2023.02.002","article-title":"Canadian Cystic Fibrosis-related Diabetes Clinical Practice Survey: Analysis of current practices and gaps in clinical care","volume":"47","author":"Potter","year":"2023","journal-title":"Can J Diabetes"},{"issue":"Suppl. 1","key":"10.1016\/j.jcjd.2024.09.001_bib8","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/j.jcjd.2017.10.002","volume":"42","author":"Sherifali","year":"2018","journal-title":"Methods. Can J Diabetes"},{"key":"10.1016\/j.jcjd.2024.09.001_bib9","series-title":"GRADE handbook for grading quality of evidence and strength of recommendations","year":"2013"},{"key":"10.1016\/j.jcjd.2024.09.001_bib10","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.2337\/dc10-1768","article-title":"Clinical care guidelines for cystic fibrosis-related diabetes: A position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society","volume":"33","author":"Moran","year":"2010","journal-title":"Diabetes Care"},{"issue":"Suppl. 1","key":"10.1016\/j.jcjd.2024.09.001_bib11","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/j.jcf.2014.03.010","article-title":"European Cystic Fibrosis Society standards of care: Best practice guidelines","volume":"13","author":"Smyth","year":"2014","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcjd.2024.09.001_bib12","doi-asserted-by":"crossref","DOI":"10.1177\/26335565221134017","article-title":"Models of care for improving health-related quality of life, mental health, or mortality in persons with multimorbidity: A systematic review of randomized controlled trials","volume":"12","author":"Eriksen","year":"2022","journal-title":"J Multimorb Comorb"},{"key":"10.1016\/j.jcjd.2024.09.001_bib13","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/j.1365-2648.2008.04797.x","article-title":"How do adults with cystic fibrosis cope following a diagnosis of diabetes?","volume":"64","author":"Collins","year":"2008","journal-title":"J\u00a0Adv Nurs"},{"key":"10.1016\/j.jcjd.2024.09.001_bib14","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/1054-139X(93)90143-D","article-title":"Transition from child-centered to adult health-care systems for adolescents with chronic conditions. A position paper of the Society for Adolescent Medicine","volume":"14","author":"Blum","year":"1993","journal-title":"J Adolesc Health"},{"key":"10.1016\/j.jcjd.2024.09.001_bib15","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.2337\/dc11-1723","volume":"34","author":"Peters","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2024.09.001_bib16","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1177\/1367493517712479","article-title":"Improving transition to adult healthcare for young people with cystic fibrosis: A systematic review","volume":"21","author":"Coyne","year":"2017","journal-title":"J\u00a0Child Health Care"},{"key":"10.1016\/j.jcjd.2024.09.001_bib17","doi-asserted-by":"crossref","first-page":"e1160","DOI":"10.1542\/peds.2007-2217","article-title":"Improving transition from pediatric to adult cystic fibrosis care: Lessons from a national survey of current practices","volume":"121","author":"McLaughlin","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.jcjd.2024.09.001_bib18","first-page":"23","article-title":"Transition to adult care in cystic fibrosis: The challenges and the structure","volume":"41","author":"Singh","year":"2022","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.jcjd.2024.09.001_bib19","article-title":"Cystic fibrosis-related diabetes: The patient perspective","volume":"26","author":"Mason","year":"2021","journal-title":"J\u00a0Clin Transl Endocrinol"},{"issue":"Suppl. 1","key":"10.1016\/j.jcjd.2024.09.001_bib20","doi-asserted-by":"crossref","first-page":"S150","DOI":"10.1016\/j.jcjd.2017.10.018","article-title":"Diabetes and driving","volume":"42","author":"Houlden","year":"2018","journal-title":"Can J Diabetes"},{"key":"10.1016\/j.jcjd.2024.09.001_bib21","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1080\/08870446.2016.1183008","article-title":"How patients' representations of cystic fibrosis-related diabetes inform their health behaviours","volume":"31","author":"Sylvain","year":"2016","journal-title":"Psychol Health"},{"key":"10.1016\/j.jcjd.2024.09.001_bib22","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jcf.2016.02.005","article-title":"Glycated hemoglobin cannot yet be proposed as a screening tool for cystic fibrosis related diabetes","volume":"15","author":"Boudreau","year":"2016","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.jcjd.2024.09.001_bib23","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jcjd.2018.04.008","article-title":"Cystic fibrosis-related diabetes screening in adults: A gap analysis and evaluation of accuracy of glycated hemoglobin levels","volume":"43","author":"Gilmour","year":"2019","journal-title":"Can J Diabetes"},{"key":"10.1016\/j.jcjd.2024.09.001_bib25","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1136\/bmj.311.7006.655","article-title":"Glucose tolerance in patients with cystic fibrosis: Five year prospective study","volume":"311","author":"Lanng","year":"1995","journal-title":"BMJ"},{"key":"10.1016\/j.jcjd.2024.09.001_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112578","article-title":"High variability in oral glucose tolerance among 1,128 patients with cystic fibrosis: A multicenter screening study","volume":"9","author":"Scheuing","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jcjd.2024.09.001_bib27","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.jcf.2016.04.004","article-title":"Variation of glucose tolerance in adult patients with cystic fibrosis: What is the potential contribution of insulin sensitivity?","volume":"15","author":"Boudreau","year":"2016","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcjd.2024.09.001_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0081545","article-title":"Diabetes in cystic fibrosis: Multicenter screening results based on current guidelines","volume":"8","author":"Scheuing","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jcjd.2024.09.001_bib29","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jcf.2015.03.013","article-title":"HbA1c as a screening tool for cystic fibrosis related diabetes","volume":"15","author":"Burgess","year":"2016","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcjd.2024.09.001_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabet.2023.101455","article-title":"A glycosylated hemoglobin A1c above 6% (42 mmol\/mol) is associated with a high risk of developing cystic fibrosis-related diabetes and a lower probability of weight gain in both adults and children with cystic fibrosis","volume":"49","author":"Potter","year":"2023","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.jcjd.2024.09.001_bib31","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.jcjd.2021.03.005","article-title":"Glycated hemoglobin as a first-line screening test for cystic fibrosis\u2012related diabetes and impaired glucose tolerance in children with cystic fibrosis: A validation study","volume":"45","author":"Racine","year":"2021","journal-title":"Can J Diabetes"},{"issue":"Suppl. 1","key":"10.1016\/j.jcjd.2024.09.001_bib32","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.jcjd.2017.10.003","article-title":"Definition, classification and diagnosis of diabetes, prediabetes and metabolic syndrome","volume":"42","author":"Punthakee","year":"2018","journal-title":"Can J Diabetes"},{"issue":"Suppl. 1","key":"10.1016\/j.jcjd.2024.09.001_bib33","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jcjd.2017.10.007","article-title":"Monitoring glycemic control","volume":"42","author":"Berard","year":"2018","journal-title":"Can J Diabetes"},{"key":"10.1016\/j.jcjd.2024.09.001_bib34","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.diabet.2008.05.010","article-title":"No relationship between mean plasma glucose and glycated haemoglobin in patients with cystic fibrosis-related diabetes","volume":"34","author":"Godbout","year":"2008","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.jcjd.2024.09.001_bib35","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jcjd.2016.08.221","article-title":"Screening for cystic fibrosis-related diabetes: Matching pathophysiology and addressing current challenges","volume":"40","author":"Boudreau","year":"2016","journal-title":"Can J Diabetes"},{"issue":"Suppl. 1","key":"10.1016\/j.jcjd.2024.09.001_bib36","doi-asserted-by":"crossref","first-page":"S255","DOI":"10.1016\/j.jcjd.2017.10.038","article-title":"Diabetes and pregnancy","volume":"42","author":"Feig","year":"2018","journal-title":"Can J Diabetes"},{"key":"10.1016\/j.jcjd.2024.09.001_bib37","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.diabres.2016.12.013","article-title":"Diabetes diagnostic thresholds of the glycated hemoglobin A1c and fasting plasma glucose levels considering the 5-year incidence of retinopathy","volume":"124","author":"Nakagami","year":"2017","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jcjd.2024.09.001_bib38","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.clnu.2016.03.004","article-title":"ESPEN-ESPGHAN-ECFS guidelines on nutrition care for infants, children, and adults with cystic fibrosis","volume":"35","author":"Turck","year":"2016","journal-title":"Clin Nutr"},{"issue":"Suppl. 2","key":"10.1016\/j.jcjd.2024.09.001_bib39","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1016\/j.jcf.2017.06.011","article-title":"Pancreatic insufficiency in cystic fibrosis","volume":"16","author":"Singh","year":"2017","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.jcjd.2024.09.001_bib40","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1016\/j.clnu.2019.12.029","article-title":"Overweight, obesity and significant weight gain in adult patients with cystic fibrosis association with lung function and cardiometabolic risk factors","volume":"39","author":"Bonhoure","year":"2020","journal-title":"Clin Nutr"},{"key":"10.1016\/j.jcjd.2024.09.001_bib41","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.2337\/dc06-1576","article-title":"Microvascular complications in cystic fibrosis-related diabetes","volume":"30","author":"Schwarzenberg","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2024.09.001_bib42","doi-asserted-by":"crossref","DOI":"10.1177\/2042018820966428","article-title":"Retinopathy and microalbuminuria are common microvascular complications in cystic fibrosis-related diabetes","volume":"11","author":"Kempegowda","year":"2020","journal-title":"Ther Adv Endocrinol Metab"},{"key":"10.1016\/j.jcjd.2024.09.001_bib43","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.2337\/dc06-0654","article-title":"Cystic fibrosis-related diabetes: The presence of microvascular diabetes complications","volume":"29","author":"Andersen","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2024.09.001_bib44","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jcf.2014.07.014","article-title":"Retinal screening of patients with cystic fibrosis-related diabetes in Wales----a real eye opener","volume":"14","author":"Roberts","year":"2015","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcjd.2024.09.001_bib45","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.2337\/dc10-2231","article-title":"Microalbuminuria in patients with cystic fibrosis","volume":"34","author":"Lind-Ayres","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2024.09.001_bib46","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00174-2023","article-title":"Prevalence, risk factors and outcomes of cardiac disease in cystic fibrosis: A multinational retrospective cohort study","author":"Frost","year":"2023","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcjd.2024.09.001_bib47","article-title":"Obesity in cystic fibrosis","volume":"26","author":"Kutney","year":"2021","journal-title":"J\u00a0Clin Transl Endocrinol"},{"issue":"Suppl. 1","key":"10.1016\/j.jcjd.2024.09.001_bib48","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/j.jcjd.2017.10.030","article-title":"Targets for glycemic control","volume":"42","author":"Imran","year":"2018","journal-title":"Can J Diabetes"},{"issue":"Suppl. 1","key":"10.1016\/j.jcjd.2024.09.001_bib49","doi-asserted-by":"crossref","first-page":"S162","DOI":"10.1016\/j.jcjd.2017.10.024","article-title":"Cardiovascular protection in people with diabetes","volume":"42","author":"Stone","year":"2018","journal-title":"Can J Diabetes"},{"issue":"Suppl. 1","key":"10.1016\/j.jcjd.2024.09.001_bib50","doi-asserted-by":"crossref","first-page":"S178","DOI":"10.1016\/j.jcjd.2017.10.019","article-title":"Dyslipidemia","volume":"42","author":"Mancini","year":"2018","journal-title":"Can J Diabetes"},{"key":"10.1016\/j.jcjd.2024.09.001_bib51","first-page":"S1","article-title":"Diabetes Canada 2018 clinical practice guidelines for the prevention and management of diabetes in Canada","volume":"42","year":"2018","journal-title":"Can J Diabetes"},{"key":"10.1016\/j.jcjd.2024.09.001_bib52","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s13300-022-01223-1","article-title":"Cystic fibrosis-related diabetes mellitus and pregnancy: A retrospective study","volume":"13","author":"Davern","year":"2022","journal-title":"Diabetes Ther"},{"issue":"Suppl. 1","key":"10.1016\/j.jcjd.2024.09.001_bib53","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/j.jcjd.2017.10.002","volume":"42","author":"Sherifali","year":"2018","journal-title":"Methods. Can J Diabetes."},{"key":"10.1016\/j.jcjd.2024.09.001_bib54","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jcjd.2023.02.002","article-title":"Canadian cystic fibrosis-related diabetes clinical practice survey: Analysis of current practices and gaps in clinical care","volume":"47","author":"Potter","year":"2023","journal-title":"Can J Diabetes"},{"issue":"Suppl. 27","key":"10.1016\/j.jcjd.2024.09.001_bib55","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/pedi.12732","article-title":"ISPAD Clinical Practice Consensus Guidelines 2018: Management of cystic fibrosis-related diabetes in children and adolescents","volume":"19","author":"Moran","year":"2018","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.jcjd.2024.09.001_bib56","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.2337\/dc10-1768","article-title":"Clinical care guidelines for cystic fibrosis-related diabetes: A position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society","volume":"33","author":"Moran","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2024.09.001_bib57","doi-asserted-by":"crossref","DOI":"10.1177\/26335565221134017","article-title":"Models of care for improving health-related quality of life, mental health, or mortality in persons with multimorbidity: A systematic review of randomized controlled trials","volume":"12","author":"Eriksen","year":"2022","journal-title":"J Multimorb Comorb"},{"key":"10.1016\/j.jcjd.2024.09.001_bib58","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2337\/cd22-as01","article-title":"Standards of Medical Care in Diabetes---2022 abridged for primary care providers","volume":"40","year":"2022","journal-title":"Clin Diabetes"},{"key":"10.1016\/j.jcjd.2024.09.001_bib59","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.chest.2021.11.035","article-title":"Real-world outcomes in cystic fibrosis telemedicine clinical care in a time of a global pandemic","volume":"161","author":"Somerville","year":"2022","journal-title":"Chest"},{"key":"10.1016\/j.jcjd.2024.09.001_bib60","first-page":"93","article-title":"Satisfaction and concerns with telemedicine endocrine care of patients with cystic fibrosis","volume":"3","author":"Ahmed","year":"2022","journal-title":"Telemed Rep"},{"key":"10.1016\/j.jcjd.2024.09.001_bib61","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.2337\/dc06-1576","article-title":"Microvascular complications in cystic fibrosis-related diabetes","volume":"30","author":"Schwarzenberg","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2024.09.001_bib62","doi-asserted-by":"crossref","DOI":"10.1177\/2042018820966428","article-title":"Retinopathy and microalbuminuria are common microvascular complications in cystic fibrosis-related diabetes","volume":"11","author":"Kempegowda","year":"2020","journal-title":"Ther Adv Endocrinol Metab"},{"key":"10.1016\/j.jcjd.2024.09.001_bib63","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1651-2227.1994.tb12956.x","article-title":"Diabetes mellitus in Danish cystic fibrosis patients: Prevalence and late diabetic complications","volume":"83","author":"Lanng","year":"1994","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.jcjd.2024.09.001_bib64","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1164\/ajrccm.162.3.9904075","article-title":"Trends in pulmonary function in patients with cystic fibrosis correlate with the degree of glucose intolerance at baseline","volume":"162","author":"Milla","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcjd.2024.09.001_bib65","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2337\/dc09-1215","article-title":"Diabetes as a determinant of mortality in cystic fibrosis","volume":"33","author":"Chamnan","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2024.09.001_bib66","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jcf.2019.07.010","article-title":"The association of pediatric cystic fibrosis-related diabetes screening on clinical outcomes by center: A CF patient registry study","volume":"19","author":"Franck Thompson","year":"2020","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.jcjd.2024.09.001_bib67","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.2337\/diacare.28.9.2141","article-title":"Diabetes is associated with dramatically decreased survival in female but not male subjects with cystic fibrosis","volume":"28","author":"Milla","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2024.09.001_bib68","first-page":"3","article-title":"Cystic fibrosis-related diabetes: Clinical approach and knowledge gaps","volume":"46","author":"Prentice","year":"2023","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.jcjd.2024.09.001_bib69","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jcf.2016.02.005","article-title":"Glycated hemoglobin cannot yet be proposed as a screening tool for cystic fibrosis related diabetes","volume":"15","author":"Boudreau","year":"2016","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.jcjd.2024.09.001_bib70","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jcjd.2018.04.008","article-title":"Cystic fibrosis-related diabetes screening in adults: A gap analysis and evaluation of accuracy of glycated hemoglobin levels","volume":"43","author":"Gilmour","year":"2019","journal-title":"Can J Diabetes"},{"key":"10.1016\/j.jcjd.2024.09.001_bib71","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jcf.2015.03.013","article-title":"HbA1c as a screening tool for cystic fibrosis related diabetes","volume":"15","author":"Burgess","year":"2016","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcjd.2024.09.001_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabet.2023.101455","article-title":"A glycosylated hemoglobin A1c above 6% (42 mmol\/mol) is associated with a high risk of developing cystic fibrosis-related diabetes and a lower probability of weight gain in both adults and children with cystic fibrosis","volume":"49","author":"Potter","year":"2023","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.jcjd.2024.09.001_bib73","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.jcjd.2021.03.005","article-title":"Glycated hemoglobin as a first-line screening test for cystic fibrosis\u2012related diabetes and impaired glucose tolerance in children with cystic fibrosis: A validation study","volume":"45","author":"Racine","year":"2021","journal-title":"Can J Diabetes"},{"key":"10.1016\/j.jcjd.2024.09.001_bib74","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1183\/09031936.05.00068104","article-title":"New criteria for impaired fasting glucose and screening for diabetes in cystic fibrosis","volume":"25","author":"Mueller-Brandes","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcjd.2024.09.001_bib75","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0081545","article-title":"Diabetes in cystic fibrosis: Multicenter screening results based on current guidelines","volume":"8","author":"Scheuing","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jcjd.2024.09.001_bib76","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jcf.2014.01.008","article-title":"The screening and diagnosis of cystic fibrosis-related diabetes in the United Kingdom","volume":"13","author":"Wickens-Mitchell","year":"2014","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.jcjd.2024.09.001_bib78","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1080\/08870446.2016.1183008","article-title":"How patients' representations of cystic fibrosis-related diabetes inform their health behaviours","volume":"31","author":"Sylvain","year":"2016","journal-title":"Psychol Health"},{"key":"10.1016\/j.jcjd.2024.09.001_bib79","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1136\/bmj.311.7006.655","article-title":"Glucose tolerance in patients with cystic fibrosis: Five year prospective study","volume":"311","author":"Lanng","year":"1995","journal-title":"BMJ"},{"key":"10.1016\/j.jcjd.2024.09.001_bib80","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112578","article-title":"High variability in oral glucose tolerance among 1,128 patients with cystic fibrosis: A multicenter screening study","volume":"9","author":"Scheuing","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jcjd.2024.09.001_bib81","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.jcf.2016.04.004","article-title":"Variation of glucose tolerance in adult patients with cystic fibrosis: What is the potential contribution of insulin sensitivity?","volume":"15","author":"Boudreau","year":"2016","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcjd.2024.09.001_bib82","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.2337\/dc09-9033","article-title":"International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes","volume":"32","year":"2009","journal-title":"Diabetes Care"},{"issue":"Suppl. 1","key":"10.1016\/j.jcjd.2024.09.001_bib83","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jcjd.2017.10.007","article-title":"Monitoring glycemic control","volume":"42","author":"Berard","year":"2018","journal-title":"Can J Diabetes"},{"issue":"Suppl. 1","key":"10.1016\/j.jcjd.2024.09.001_bib84","first-page":"S255","article-title":"Diabetes and pregnancy","volume":"42","author":"Feig","year":"2017","journal-title":"Can J Diabetes"},{"key":"10.1016\/j.jcjd.2024.09.001_bib85","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.673539","article-title":"Diabetes and prediabetes in children with cystic fibrosis: A systematic review of the literature and recommendations of the Italian Society for Pediatric Endocrinology and Diabetes (ISPED)","volume":"12","author":"Mozzillo","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jcjd.2024.09.001_bib86","author":"Littlewood"},{"key":"10.1016\/j.jcjd.2024.09.001_bib87","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1399-5448.2009.00632.x","article-title":"Oral glucose tolerance testing in children with cystic fibrosis","volume":"11","author":"Ode","year":"2010","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.jcjd.2024.09.001_bib88","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.2337\/dc16-0020","article-title":"Does \u03b2-cell autoimmunity play a role in cystic fibrosis-related diabetes? Analysis based on the German\/Austrian Diabetes Patienten Verlaufsdokumentation Registry","volume":"39","author":"Konrad","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2024.09.001_bib89","article-title":"Obesity in cystic fibrosis","volume":"26","author":"Kutney","year":"2021","journal-title":"J\u00a0Clin Transl Endocrinol"},{"key":"10.1016\/j.jcjd.2024.09.001_bib90","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jcf.2021.11.012","article-title":"Effect of elexacaftor-tezacaftor-ivacaftor on body weight and metabolic parameters in adults with cystic fibrosis","volume":"21","author":"Petersen","year":"2022","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.jcjd.2024.09.001_bib91","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1007\/s00125-009-1436-2","article-title":"A susceptibility gene for type 2 diabetes confers substantial risk for diabetes complicating cystic fibrosis","volume":"52","author":"Blackman","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.jcjd.2024.09.001_bib92","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1055\/s-0029-1232567","article-title":"No association between the deltaF508 cystic fibrosis mutation and type 2 diabetes mellitus","volume":"107","author":"Braun","year":"1999","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"Suppl. 1","key":"10.1016\/j.jcjd.2024.09.001_bib93","first-page":"S1","article-title":"Diabetes Canada 2018 clinical practice guidelines for the prevention and management of diabetes in Canada","volume":"42","year":"2018","journal-title":"Can J Diabetes"},{"issue":"Suppl. 1","key":"10.1016\/j.jcjd.2024.09.001_bib94","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.jcjd.2017.10.003","article-title":"Definition, classification and diagnosis of diabetes, prediabetes and metabolic syndrome","volume":"42","author":"Punthakee","year":"2018","journal-title":"Can J Diabetes"},{"key":"10.1016\/j.jcjd.2024.09.001_bib95","article-title":"Comparing self monitoring blood glucose devices and laboratory tests: Over 25 years experience","volume":"11","author":"Harada","year":"2019","journal-title":"Cureus"},{"key":"10.1016\/j.jcjd.2024.09.001_bib96","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ando.2022.09.025","article-title":"Marginal association of fasting blood glucose with the risk of cystic fibrosis-related diabetes","volume":"84","author":"Potter","year":"2023","journal-title":"Ann Endocrinol (Paris)"},{"key":"10.1016\/j.jcjd.2024.09.001_bib97","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1139\/apnm-2013-0022","article-title":"Diagnosis of cystic fibrosis-related glucose abnormalities: Can we shorten the standard oral glucose tolerance test?","volume":"38","author":"Coriati","year":"2013","journal-title":"Appl Physiol Nutr Metab"},{"key":"10.1016\/j.jcjd.2024.09.001_bib98","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jcf.2015.03.001","article-title":"Characterization of patients with cystic fibrosis presenting an indeterminate glucose tolerance (INDET)","volume":"15","author":"Coriati","year":"2016","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.jcjd.2024.09.001_bib99","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0246897","article-title":"Impact of 1h oral glucose tolerance test on the clinical status of adult cystic fibrosis patients over a 4-year period","volume":"16","author":"Boudreau","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.jcjd.2024.09.001_bib100","doi-asserted-by":"crossref","first-page":"e3901","DOI":"10.1210\/clinem\/dgab384","article-title":"Combined indeterminate and impaired glucose tolerance is a novel group at high risk of cystic fibrosis-related diabetes","volume":"106","author":"Potter","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jcjd.2024.09.001_bib101","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.jcjd.2021.11.004","article-title":"Prevalence of post-glucose challenge hypoglycemia in adult patients with cystic fibrosis and relevance to the risk of cystic fibrosis-related diabetes","volume":"46","author":"Bonhoure","year":"2022","journal-title":"Can J Diabetes"},{"key":"10.1016\/j.jcjd.2024.09.001_bib102","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jcf.2018.03.009","article-title":"Prevalence of hypoglycemia during oral glucose tolerance testing in adults with cystic fibrosis and risk of developing cystic fibrosis-related diabetes","volume":"17","author":"Mannik","year":"2018","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcjd.2024.09.001_bib103","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00592-015-0791-3","article-title":"The 1-h oral glucose tolerance test glucose and insulin values are associated with markers of clinical deterioration in cystic fibrosis","volume":"53","author":"Coriati","year":"2016","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.jcjd.2024.09.001_bib104","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jcf.2019.07.006","article-title":"Dysregulated insulin in pancreatic insufficient cystic fibrosis with post-prandial hypoglycemia","volume":"19","author":"Kilberg","year":"2020","journal-title":"J Cyst Fibros"},{"issue":"Suppl. 1","key":"10.1016\/j.jcjd.2024.09.001_bib105","first-page":"S104","article-title":"Hypoglycemia","volume":"42","author":"Yale","year":"2017","journal-title":"Can J Diabetes"},{"key":"10.1016\/j.jcjd.2024.09.001_bib106","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jcf.2008.11.002","article-title":"Dichotomy between postprandial glucose and lipid profiles in adults with cystic fibrosis: A pilot study","volume":"8","author":"Hammana","year":"2009","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcjd.2024.09.001_bib107","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.2337\/dc08-1925","article-title":"Validation of continuous glucose monitoring in children and adolescents with cystic fibrosis: A prospective cohort study","volume":"32","author":"O\u2019Riordan","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2024.09.001_bib108","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/pdi.1588","article-title":"Insulin therapy in patients with cystic fibrosis related diabetes mellitus: Benefit, timing of initiation and hypoglycaemia","volume":"28","author":"Drummond","year":"2011","journal-title":"Pract Diabetes Int"},{"key":"10.1016\/j.jcjd.2024.09.001_bib109","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jcf.2007.07.004","article-title":"Glargine versus NPH insulin in cystic fibrosis related diabetes","volume":"7","author":"Grover","year":"2008","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.jcjd.2024.09.001_bib110","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s13300-016-0194-7","article-title":"Patterns and impact of hypoglycemia, hyperglycemia, and glucose variability on inpatients with insulin-treated cystic fibrosis-related diabetes","volume":"7","author":"Jones","year":"2016","journal-title":"Diabetes Ther"},{"issue":"Suppl. 1","key":"10.1016\/j.jcjd.2024.09.001_bib111","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/j.jcjd.2017.10.030","article-title":"Targets for glycemic control","volume":"42","author":"Imran","year":"2018","journal-title":"Can J Diabetes"},{"issue":"Suppl. 1","key":"10.1016\/j.jcjd.2024.09.001_bib112","first-page":"S247","article-title":"Type 2 diabetes in children and adolescents","volume":"42","author":"Panagiotopoulos","year":"2017","journal-title":"Can J Diabetes"},{"issue":"Suppl. 27","key":"10.1016\/j.jcjd.2024.09.001_bib113","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/pedi.12737","article-title":"ISPAD Clinical Practice Consensus Guidelines 2018: Glycemic control targets and glucose monitoring for children, adolescents, and young adults with diabetes","volume":"19","author":"DiMeglio","year":"2018","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.jcjd.2024.09.001_bib114","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1177\/0884533613507086","article-title":"Malnutrition in cystic fibrosis: A review","volume":"28","author":"Culhane","year":"2013","journal-title":"Nutr Clin Pract"},{"key":"10.1016\/j.jcjd.2024.09.001_bib115","first-page":"515","article-title":"Protein is an important but undervalued macronutrient in the nutritional care of patients with cystic fibrosis","volume":"17","author":"Engelen","year":"2014","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.jcjd.2024.09.001_bib116","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0895-4356(88)90063-7","article-title":"A\u00a0comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto","volume":"41","author":"Corey","year":"1988","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.jcjd.2024.09.001_bib117","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.clnu.2016.03.004","article-title":"ESPEN-ESPGHAN-ECFS guidelines on nutrition care for infants, children, and adults with cystic fibrosis","volume":"35","author":"Turck","year":"2016","journal-title":"Clin Nutr"},{"issue":"Suppl. 2","key":"10.1016\/j.jcjd.2024.09.001_bib118","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1016\/j.jcf.2017.06.011","article-title":"Pancreatic insufficiency in cystic fibrosis","volume":"16","author":"Singh","year":"2017","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.jcjd.2024.09.001_bib119","doi-asserted-by":"crossref","DOI":"10.3390\/nu14061216","article-title":"The changing landscape of nutrition in cystic fibrosis: The emergence of overweight and obesity","volume":"14","author":"Bailey","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.jcjd.2024.09.001_bib120","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.jand.2020.03.015","article-title":"Academy of Nutrition and Dietetics: 2020 cystic fibrosis evidence analysis center evidence-based nutrition practice guideline","volume":"121","author":"McDonald","year":"2021","journal-title":"J Acad Nutr Diet"},{"key":"10.1016\/j.jcjd.2024.09.001_bib121","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jcf.2022.03.010","article-title":"Obesity in cystic fibrosis: Prevalence, trends and associated factors data from the US Cystic Fibrosis Foundation Patient Registry","volume":"21","author":"Szentpetery","year":"2022","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.jcjd.2024.09.001_bib122","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1164\/rccm.202108-1986OC","article-title":"Clinical effectiveness of elexacaftor\/tezacaftor\/ivacaftor in people with cystic fibrosis: A clinical trial","volume":"205","author":"Nichols","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"issue":"Suppl. 1","key":"10.1016\/j.jcjd.2024.09.001_bib123","first-page":"S40","article-title":"Overweight and cystic fibrosis: An unexpected challenge","volume":"57","author":"Gabel","year":"2022","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcjd.2024.09.001_bib124","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.chest.2021.11.001","article-title":"Emerging nonpulmonary complications for adults with cystic fibrosis: Adult cystic fibrosis series","volume":"161","author":"Chin","year":"2022","journal-title":"Chest"},{"key":"10.1016\/j.jcjd.2024.09.001_bib125","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1111\/pedi.13453","article-title":"ISPAD Clinical Practice Consensus Guidelines 2022: Management of cystic fibrosis-related diabetes in children and adolescents","volume":"23","author":"Ode","year":"2022","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.jcjd.2024.09.001_bib126","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.jand.2020.03.016","article-title":"Dietary macronutrient distribution and nutrition outcomes in persons with cystic fibrosis: An evidence analysis center systematic review","volume":"121","author":"McDonald","year":"2021","journal-title":"J\u00a0Acad Nutr Diet"},{"key":"10.1016\/j.jcjd.2024.09.001_bib127","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S1569-1993(02)00032-2","article-title":"Nutrition in patients with cystic fibrosis: A European consensus","volume":"1","author":"Sinaasappel","year":"2002","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcjd.2024.09.001_bib128","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1016\/j.clnu.2019.12.029","article-title":"Overweight, obesity and significant weight gain in adult patients with cystic fibrosis association with lung function and cardiometabolic risk factors","volume":"39","author":"Bonhoure","year":"2020","journal-title":"Clin Nutr"},{"key":"10.1016\/j.jcjd.2024.09.001_bib129","series-title":"Nutrition Guidelines for Cystic Fibrosis in Australia and New Zealand","author":"Saxby","year":"2017"},{"key":"10.1016\/j.jcjd.2024.09.001_bib130","doi-asserted-by":"crossref","first-page":"Itc81","DOI":"10.7326\/AITC201712050","article-title":"Dyslipidemia","volume":"167","author":"Kopin","year":"2017","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jcjd.2024.09.001_bib131","first-page":"610","article-title":"Evaluation of dietary fiber intake in Belgian children with cystic fibrosis: Is there a link with gastrointestinal complaints?","volume":"35","author":"Proesmans","year":"2002","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jcjd.2024.09.001_bib132","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jcf.2009.11.003","article-title":"Constipation in pediatric cystic fibrosis patients: An underestimated medical condition","volume":"9","author":"van der Doef","year":"2010","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.jcjd.2024.09.001_bib133","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1177\/0884533614551838","article-title":"Nutrition and pancreatic enzyme intake in patients with cystic fibrosis with distal intestinal obstruction syndrome","volume":"30","author":"Declercq","year":"2015","journal-title":"Nutr Clin Pract"},{"key":"10.1016\/j.jcjd.2024.09.001_bib134","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.ando.2023.02.001","article-title":"Acute soluble fibre supplementation has no impact on reducing post-prandial glucose excursions in adults with cystic fibrosis and glucose intolerance","volume":"84","author":"Lehoux Dubois","year":"2023","journal-title":"Ann Endocrinol (Paris)"},{"key":"10.1016\/j.jcjd.2024.09.001_bib135","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1080\/16066350801902467","article-title":"Should alcohol policies aim to reduce total alcohol consumption? New analyses of Canadian drinking patterns","volume":"17","author":"Stockwell","year":"2009","journal-title":"Addict Res Theory"},{"key":"10.1016\/j.jcjd.2024.09.001_bib136","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1016\/j.clnu.2018.08.013","article-title":"Extra-skeletal impact of vitamin D supplementation protocol in an adult population with cystic fibrosis","volume":"38","author":"Lehoux Dubois","year":"2019","journal-title":"Clin Nutr"},{"key":"10.1016\/j.jcjd.2024.09.001_bib137","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.diabet.2015.11.002","article-title":"Relationship between vitamin D levels and glucose tolerance in an adult population with cystic fibrosis","volume":"42","author":"Coriati","year":"2016","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.jcjd.2024.09.001_bib138","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.clnu.2016.10.002","article-title":"Vitamin D(3) supplementation among adult patients with cystic fibrosis","volume":"36","author":"Coriati","year":"2017","journal-title":"Clin Nutr"},{"key":"10.1016\/j.jcjd.2024.09.001_bib141","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1249\/MSS.0000000000001104","article-title":"Combined exercise training improves glycemic control in adult with cystic fibrosis","volume":"49","author":"Beaudoin","year":"2017","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/j.jcjd.2024.09.001_bib142","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s00408-020-00396-5","article-title":"Influence of cystic fibrosis-related diabetes on mental health in adults: A single-center study","volume":"198","author":"Hjelm","year":"2020","journal-title":"Lung"},{"key":"10.1016\/j.jcjd.2024.09.001_bib143","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.jcf.2019.03.007","article-title":"The impact of cystic fibrosis-related diabetes on health-related quality of life","volume":"18","author":"Kwong","year":"2019","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcjd.2024.09.001_bib144","article-title":"Emotional distress, self-management, and glycemic control among participants enrolled in the glycemia reduction approaches in diabetes: A comparative effectiveness (GRADE) study","author":"Gonzalez","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jcjd.2024.09.001_bib145","first-page":"860","article-title":"Cystic fibrosis-related diabetes mellitus: Clinical impact of prediabetes and effects of insulin therapy","volume":"90","author":"Rolon","year":"2001","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.jcjd.2024.09.001_bib146","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.2337\/dc09-0585","article-title":"Insulin therapy to improve BMI in cystic fibrosis-related diabetes without fasting hyperglycemia: Results of the cystic fibrosis related diabetes therapy trial","volume":"32","author":"Moran","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2024.09.001_bib147","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/j.1651-2227.1994.tb13156.x","article-title":"Diabetes mellitus in cystic fibrosis: Effect of insulin therapy on lung function and infections","volume":"83","author":"Lanng","year":"1994","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.jcjd.2024.09.001_bib148","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2021.659728","article-title":"Continuous glucose monitoring as a valuable tool in the early detection of diabetes related to cystic fibrosis","volume":"9","author":"Gojsina","year":"2021","journal-title":"Front Pediatr"},{"key":"10.1016\/j.jcjd.2024.09.001_bib149","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000110206","article-title":"Long-term effect of insulin treatment in cystic fibrosis-related diabetes","volume":"76","author":"Mohan","year":"2008","journal-title":"Respiration"},{"key":"10.1016\/j.jcjd.2024.09.001_bib150","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S2213-8587(17)30400-X","article-title":"Repaglinide versus insulin for newly diagnosed diabetes in patients with cystic fibrosis: A multicentre, open-label, randomised trial","volume":"6","author":"Ballmann","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jcjd.2024.09.001_bib151","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.clnu.2014.08.016","article-title":"Carbohydrate intake and insulin requirement in children, adolescents and young adults with cystic fibrosis-related diabetes: A multicenter comparison to type 1 diabetes","volume":"34","author":"Scheuing","year":"2015","journal-title":"Clin Nutr"},{"key":"10.1016\/j.jcjd.2024.09.001_bib152","doi-asserted-by":"crossref","first-page":"879","DOI":"10.2337\/dc12-0807","article-title":"Comparison of cystic fibrosis-related diabetes with type 1 diabetes based on a German\/Austrian Pediatric Diabetes Registry","volume":"36","author":"Konrad","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2024.09.001_bib153","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/pedi.12014","article-title":"Exogenous insulin requirements do not differ between youth and adults with cystic fibrosis related diabetes","volume":"14","author":"Sunni","year":"2013","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.jcjd.2024.09.001_bib154","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.2337\/diacare.24.10.1706","article-title":"Insulin and glucose excursion following premeal insulin lispro or repaglinide in cystic fibrosis-related diabetes","volume":"24","author":"Moran","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2024.09.001_bib155","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1016\/j.clgc.2014.11.004","article-title":"Efficacy and safety of an attenuated-dose sunitinib regimen in metastatic renal cell carcinoma: Results from a prospective registry in Singapore","volume":"13","author":"Tan","year":"2015","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.jcjd.2024.09.001_bib156","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/ajcn.81.2.421","article-title":"Changes in response to insulin and the effects of varying glucose tolerance on whole-body protein metabolism in patients with cystic fibrosis","volume":"81","author":"Rafii","year":"2005","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jcjd.2024.09.001_bib157","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jcjd.2020.08.001","article-title":"Pharmacologic glycemic management of type 2 diabetes in adults: 2020 update","volume":"44","author":"Lipscombe","year":"2022","journal-title":"Can J Diabetes"},{"key":"10.1016\/j.jcjd.2024.09.001_bib158","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1007\/s00125-022-05787-2","article-title":"Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"65","author":"Davies","year":"2022","journal-title":"Diabetologia"},{"key":"10.1016\/j.jcjd.2024.09.001_bib159","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1111\/dme.14121","article-title":"Loss of incretin effect contributes to postprandial hyperglycaemia in cystic fibrosis-related diabetes","volume":"36","author":"Frost","year":"2019","journal-title":"Diabet Med"},{"key":"10.1016\/j.jcjd.2024.09.001_bib160","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/dom.13544","article-title":"Exenatide corrects postprandial hyperglycaemia in young people with cystic fibrosis and impaired glucose tolerance: A randomized crossover trial","volume":"21","author":"Geyer","year":"2019","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jcjd.2024.09.001_bib161","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1210\/clinem\/dgab365","article-title":"Effect of sitagliptin on islet function in pancreatic insufficient cystic fibrosis with abnormal glucose tolerance","volume":"106","author":"Kelly","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jcjd.2024.09.001_bib162","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11061754","article-title":"Continuous glucose monitoring as an additional tool in early cystic fibrosis-related diabetes monitoring and in evaluation of short-term sitagliptin response","volume":"11","author":"Sebastian-Valles","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.jcjd.2024.09.001_bib163","doi-asserted-by":"crossref","DOI":"10.1007\/s00592-024-02289-y","article-title":"A\u00a0comprehensive meta-analysis on the association of SGLT2is and GLP-1RAs with vascular diseases, digestive diseases and fractures","author":"Wang","year":"2024","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.jcjd.2024.09.001_bib164","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1043789","article-title":"Association between different GLP-1 receptor agonists and gastrointestinal adverse reactions: A real-world disproportionality study based on FDA adverse event reporting system database","volume":"13","author":"Liu","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jcjd.2024.09.001_bib165","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcf.2024.06.007","article-title":"Role for DPP4 inhibitor therapy in cystic fibrosis related diabetes: A single centre experience","author":"Santhakumar","year":"2024","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcjd.2024.09.001_bib166","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa167","article-title":"Semaglutide in cystic fibrosis-related diabetes","volume":"105","author":"Gnanapragasam","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jcjd.2024.09.001_bib167","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.jpeds.2005.06.003","article-title":"Overweight and obesity in deltaF508 homozygous cystic fibrosis","volume":"147","author":"Kastner-Cole","year":"2005","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.jcjd.2024.09.001_bib168","doi-asserted-by":"crossref","first-page":"872","DOI":"10.3945\/ajcn.112.051409","article-title":"Longitudinal trends in nutritional status and the relation between lung function and BMI in cystic fibrosis: A population-based cohort study","volume":"97","author":"Stephenson","year":"2013","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jcjd.2024.09.001_bib169","doi-asserted-by":"crossref","first-page":"85","DOI":"10.4239\/wjd.v13.i2.85","article-title":"Role of dipeptidyl peptidase 4 inhibitors in the new era of antidiabetic treatment","volume":"13","author":"Florentin","year":"2022","journal-title":"World J Diabetes"},{"key":"10.1016\/j.jcjd.2024.09.001_bib170","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1111\/j.1464-5491.2011.03256.x","article-title":"Sensor-augmented pump therapy lowers HbA(1c) in suboptimally controlled Type 1 diabetes; a randomized controlled trial","volume":"28","author":"Hermanides","year":"2011","journal-title":"Diabet Med"},{"key":"10.1016\/j.jcjd.2024.09.001_bib171","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1002853","article-title":"Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes","volume":"363","author":"Bergenstal","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcjd.2024.09.001_bib172","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/pedi.12158","article-title":"Why is insulin pump treatment rarely used in adolescents and young adults with cystic fibrosis-related diabetes?","volume":"16","author":"Scheuing","year":"2015","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.jcjd.2024.09.001_bib173","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jcf.2008.12.001","article-title":"Use of the insulin pump in treat cystic fibrosis related diabetes","volume":"8","author":"Hardin","year":"2009","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.jcjd.2024.09.001_bib174","doi-asserted-by":"crossref","first-page":"1228153","DOI":"10.3389\/fendo.2023.1228153","article-title":"Effects of insulin therapy optimization with sensor augmented pumps on glycemic control and body composition in people with cystic fibrosis-related diabetes","volume":"14","author":"Grancini","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jcjd.2024.09.001_bib175","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s11892-020-01339-3","article-title":"Assessment of risks and benefits of beta cell replacement versus automated insulin delivery systems for type 1 diabetes","volume":"20","author":"Senior","year":"2020","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.jcjd.2024.09.001_bib176","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jcf.2019.08.002","article-title":"Automated glycemic control with the bionic pancreas in cystic fibrosis-related diabetes: A pilot study","volume":"19","author":"Sherwood","year":"2020","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcjd.2024.09.001_bib177","article-title":"Randomized trial of the insulin-only iLet bionic pancreas for the treatment of cystic fibrosis\u2013related diabetes","author":"Sherwood","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2024.09.001_bib179","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2020.107845","article-title":"Effect of CFTR modulator therapy on cystic fibrosis-related diabetes","volume":"35","author":"Gaines","year":"2021","journal-title":"J\u00a0Diabetes Complications"},{"key":"10.1016\/j.jcjd.2024.09.001_bib180","article-title":"Sustained glycemic control with ivacaftor in cystic fibrosis-related diabetes","volume":"7","author":"Christian","year":"2019","journal-title":"J\u00a0Investig Med High Impact Case Rep"},{"key":"10.1016\/j.jcjd.2024.09.001_bib181","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jcf.2020.03.002","article-title":"Effect of one-year lumacaftor-ivacaftor treatment on glucose tolerance abnormalities in cystic fibrosis patients","volume":"19","author":"Misgault","year":"2020","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcjd.2024.09.001_bib182","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jcf.2020.09.001","article-title":"Lumacaftor\/ivacaftor therapy fails to increase insulin secretion in F508del\/F508del CF patients","volume":"20","author":"Moheet","year":"2021","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcjd.2024.09.001_bib183","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1007\/s40618-021-01525-4","article-title":"Lumacaftor\/ivacaftor in cystic fibrosis: Effects on glucose metabolism and insulin secretion","volume":"44","author":"Colombo","year":"2021","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.jcjd.2024.09.001_bib184","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jcf.2017.11.016","article-title":"Effect of Lumacaftor\/ivacaftor on glucose metabolism and insulin secretion in Phe508del homozygous cystic fibrosis patients","volume":"17","author":"Thomassen","year":"2018","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.jcjd.2024.09.001_bib185","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jcf.2018.07.010","article-title":"Continuous glucose monitoring in youth with cystic fibrosis treated with lumacaftor-ivacaftor","volume":"18","author":"Li","year":"2019","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcjd.2024.09.001_bib186","doi-asserted-by":"crossref","first-page":"852551","DOI":"10.3389\/fped.2022.852551","article-title":"Short-term effects of elexacaftor\/tezacaftor\/ivacaftor combination on glucose tolerance in young people with cystic fibrosis---an observational pilot study","volume":"10","author":"Korten","year":"2022","journal-title":"Front Pediatr"},{"key":"10.1016\/j.jcjd.2024.09.001_bib187","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1136\/thoraxjnl-2017-210394","article-title":"Data from the US and UK cystic fibrosis registries support disease modification by CFTR modulation with ivacaftor","volume":"73","author":"Bessonova","year":"2018","journal-title":"Thorax"},{"key":"10.1016\/j.jcjd.2024.09.001_bib188","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jcf.2019.05.015","article-title":"Disease progression in patients with cystic fibrosis treated with ivacaftor: Data from national US and UK registries","volume":"19","author":"Volkova","year":"2020","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcjd.2024.09.001_bib189","article-title":"The effects of elexacaftor, tezacaftor, and ivacaftor (ETI) on blood glucose in patients with cystic fibrosis: A systematic review","volume":"15","author":"Salazar-Barragan","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.jcjd.2024.09.001_bib190","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1056\/NEJMoa0707943","article-title":"Hyperglycemia and adverse pregnancy outcomes","volume":"358","author":"Metzger","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcjd.2024.09.001_bib191","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1111\/aogs.13185","article-title":"Pregnancy outcome in women with cystic fibrosis-related diabetes","volume":"96","author":"Reynaud","year":"2017","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.jcjd.2024.09.001_bib192","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s13300-022-01223-1","article-title":"Cystic fibrosis-related diabetes mellitus and pregnancy: A retrospective study","volume":"13","author":"Davern","year":"2022","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.jcjd.2024.09.001_bib193","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1159\/000522431","article-title":"Stress and diabetes mellitus: Pathogenetic mechanisms and clinical outcome","volume":"96","author":"Ingrosso","year":"2023","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/j.jcjd.2024.09.001_bib194","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1177\/193229681200600507","article-title":"Cystic fibrosis-related diabetes in adults: Inpatient management of 121 patients during 410 admissions","volume":"6","author":"Rasouli","year":"2012","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/j.jcjd.2024.09.001_bib195","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jcf.2019.12.016","article-title":"Glycemic control and FEV(1) recovery during pulmonary exacerbations in pediatric cystic fibrosis-related diabetes","volume":"19","author":"Okoniewski","year":"2020","journal-title":"J\u00a0Cyst Fibros"},{"issue":"Suppl. 1","key":"10.1016\/j.jcjd.2024.09.001_bib196","first-page":"S115","article-title":"In-hospital management of diabetes","volume":"42","author":"Malcolm","year":"2017","journal-title":"Can J Diabetes"},{"key":"10.1016\/j.jcjd.2024.09.001_bib197","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.jcf.2019.04.015","article-title":"Incidence and risk factors of paediatric cystic fibrosis-related diabetes","volume":"18","author":"Perrem","year":"2019","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.jcjd.2024.09.001_bib198","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jcf.2018.01.004","article-title":"The effect of enteral tube feeding in cystic fibrosis: A registry based study","volume":"17","author":"Libeert","year":"2018","journal-title":"J Cyst Fibros"},{"issue":"Suppl. 2","key":"10.1016\/j.jcjd.2024.09.001_bib199","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.jcf.2019.08.003","article-title":"Cystic fibrosis related diabetes: Medical management","volume":"18","author":"Ode","year":"2019","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.jcjd.2024.09.001_bib200","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00014-2021","article-title":"Impact of a high emergency lung transplantation programme for cystic fibrosis in France: Insight from a comparison with Canada","volume":"59","author":"Coriati","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcjd.2024.09.001_bib201","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1111\/j.1464-5491.2012.03676.x","article-title":"Diabetes before and after lung transplantation in patients with cystic fibrosis and other lung diseases","volume":"29","author":"Belle-van Meerkerk","year":"2012","journal-title":"Diabet Med"},{"key":"10.1016\/j.jcjd.2024.09.001_bib202","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.healun.2020.02.010","article-title":"Lung transplantation for cystic fibrosis","volume":"39","author":"Yeung","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jcjd.2024.09.001_bib203","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1136\/thx.2007.092056","article-title":"Outcomes of lung transplantation for cystic fibrosis in a large UK cohort","volume":"63","author":"Meachery","year":"2008","journal-title":"Thorax"},{"key":"10.1016\/j.jcjd.2024.09.001_bib204","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.2337\/dc14-0663","article-title":"Prevalence and predictors of diabetes after lung transplantation: a prospective, longitudinal study","volume":"37","author":"Hackman","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2024.09.001_bib205","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1093\/ndt\/gfs583","article-title":"Novel views on new-onset diabetes after transplantation: Development, prevention and treatment","volume":"28","author":"Hecking","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jcjd.2024.09.001_bib206","doi-asserted-by":"crossref","first-page":"254","DOI":"10.4158\/EP-2018-0461","article-title":"Markedly delayed insulin secretion and a high rate of undetected overt diabetes characterize glucose metabolism in adult patients with cystic fibrosis after lung transplantation","volume":"25","author":"Winhofer","year":"2019","journal-title":"Endocr Pract"},{"issue":"Suppl. 2","key":"10.1016\/j.jcjd.2024.09.001_bib207","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.jcf.2019.08.016","article-title":"Cystic fibrosis related diabetes: Pathophysiology, screening and diagnosis","volume":"18","author":"Granados","year":"2019","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.jcjd.2024.09.001_bib208","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.healun.2021.04.011","article-title":"Cystic fibrosis foundation consensus statements for the care of cystic fibrosis lung transplant recipients","volume":"40","author":"Shah","year":"2021","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jcjd.2024.09.001_bib209","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1097\/TP.0b013e3182a012f3","article-title":"Screening for new-onset diabetes after kidney transplantation: Limitations of fasting glucose and advantages of afternoon glucose and glycated hemoglobin","volume":"96","author":"Yates","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.jcjd.2024.09.001_bib210","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1111\/ajt.12850","article-title":"Proceedings from an international consensus meeting on posttransplantation diabetes mellitus: Recommendations and future directions","volume":"14","author":"Sharif","year":"2014","journal-title":"Am J Transplant"},{"issue":"Suppl. 2","key":"10.1016\/j.jcjd.2024.09.001_bib211","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.1016\/j.jcf.2019.08.019","article-title":"Endocrine complications after solid-organ transplant in cystic fibrosis","volume":"18","author":"Sidhaye","year":"2019","journal-title":"J\u00a0Cyst Fibros"},{"issue":"Suppl. 1","key":"10.1016\/j.jcjd.2024.09.001_bib212","doi-asserted-by":"crossref","first-page":"S145","DOI":"10.1016\/j.jcjd.2017.10.017","article-title":"Diabetes and transplantation","volume":"42","author":"Senior","year":"2018","journal-title":"Can J Diabetes"},{"key":"10.1016\/j.jcjd.2024.09.001_bib213","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jcf.2018.10.013","article-title":"Pre-transplant factors associated with mortality after lung transplantation in cystic fibrosis: A systematic review and meta-analysis","volume":"18","author":"Koutsokera","year":"2019","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcjd.2024.09.001_bib214","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/s41574-018-0137-7","article-title":"Post-transplant diabetes mellitus in patients with solid organ transplants","volume":"15","author":"Jenssen","year":"2019","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.jcjd.2024.09.001_bib215","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1111\/dme.13675","article-title":"Management of hyperglycaemia and steroid (glucocorticoid) therapy: A guideline from the Joint British Diabetes Societies (JBDS) for Inpatient Care Group","volume":"35","author":"Roberts","year":"2018","journal-title":"Diabet Med"},{"key":"10.1016\/j.jcjd.2024.09.001_bib216","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1210\/jc.2004-0699","article-title":"Sulfonylurea induced beta-cell apoptosis in cultured human islets","volume":"90","author":"Maedler","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jcjd.2024.09.001_bib217","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.trre.2016.09.001","article-title":"Drug-drug interactions between immunosuppressants and antidiabetic drugs in the treatment of post-transplant diabetes mellitus","volume":"31","author":"Vanhove","year":"2017","journal-title":"Transplant Rev (Orlando)"}],"container-title":["Canadian Journal of Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499267124001783?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499267124001783?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T20:36:57Z","timestamp":1762547817000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1499267124001783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":211,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S1499267124001783"],"URL":"https:\/\/doi.org\/10.1016\/j.jcjd.2024.09.001","relation":{},"ISSN":["1499-2671"],"issn-type":[{"value":"1499-2671","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cystic Fibrosis\u2013related Diabetes: A First Canadian Clinical Practice\u00a0Guideline","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Diabetes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcjd.2024.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published on behalf of the Canadian Diabetes Association.","name":"copyright","label":"Copyright"}]}}